FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer-Reference-Cited by-同舟云学术

FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer

Published:2016-12-28 Issue:1 Volume:6 Page:275-287
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wang Jinhua¹²,Xu Yali³,Li Li¹,Wang Lin¹,Yao Ru³,Sun Qiang³,Du Guanhua¹

Affiliation:

1. The State Key Laboratory of Bioactive Substance and Function of Natural Medicines; Beijing Key Laboratory of Drug Target Research and Drug Screen; Institute of Materia Medica; Chinese Academy of Medical Science and Peking Union Medical College; Beijing 100050 China

2. Department of Molecular Oncology; John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center; Santa Monica California 90404

3. Department of Breast Surgery; Peking Union Medical College Hospital; Peking Union Medical College; Chinese Academy of Medical Sciences; Beijing 100032 China

Funder

National Natural Science Foundation of China

National Science and Technology Major Projects for “Major New Drugs Innovation and Development”

CAMS Initiative for Innovative Medicine (CAMS-I2M)

Associates for Breast and Prostate Cancer Research and Margie and Robert E. Peterson breast cancer program

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.990/fullpdf

Reference33 articles.